A private equity firm is reportedly offloading a mental health chain into the municipal bond market, a strategic move that is drawing attention due to the complexities often associated with private equity ownership in the healthcare sector. This approach allows the PE firm to exit its investment by tapping into public financing, which typically offers lower interest rates than traditional corporate bonds.
The context of this sale highlights the broader trend of private equity involvement in healthcare, where firms often acquire companies based on their EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) with significant leverage. However, as noted by Michael Darcy, a clean EBITDA number on a term sheet can lead to messy outcomes on the ground, especially when debt burdens eat into operational plans. Median leverage in private equity healthcare buyouts is around 7x EBITDA, which can strain a company's financial health if operational targets are missed, as debt covenant math often assumes conversion rates that models fail to adequately stress test. Such pressures can lead to issues like increased AR days and higher denial rates.
The sale also brings to light the fluctuating landscape of the healthcare industry. For example, Acadia Healthcare (NASDAQ: ACHC), a mental healthcare provider, recently reported Q1 earnings of $0.37 EPS, surpassing analyst estimates of $0.28 EPS, with revenues of $828.80 million, up 7.6% year-over-year. Analysts anticipate Acadia Healthcare will report Q2 earnings of $0.33 per share and revenue of $844.1920 million. This contrasts with other situations like GoHealth, which recently completed a financial restructuring and emerged from Chapter 11 bankruptcy, transitioning ownership to its lenders and becoming a private company. Such varied outcomes underscore the risks and opportunities within the healthcare market, particularly for companies under private equity ownership.
